Trial intelligence / Profile preview

Diazepam Buccal Film vs Rectal Gel in Adult Epilepsy

NCT03953820Phase 2Completed

Sponsor
Aquestive Therapeutics
Start
Apr 2019
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of libervant in epilepsy (3 arms), sponsored by Aquestive Therapeutics. Primary endpoints: Area Under the Curve from time 0 to time t at 240 hours, Area Under the Curve from time 0 to infinity at 240 hours and 1 more. Started Apr 2019; status: completed.

02

Drugs

libervant
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT03953820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03953820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call